Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
- B4950 Darunavir EthanolateSummary: nonpeptidic HIV protease inhibitor
- A4432 ARP 1001 CitationTarget: MMPSummary: Selective MMP-2 inhibitor
- A4433 ARP 1011 CitationSummary: MMP inhibitor,potent and selective
- A4416 AZ 10417808Target: CaspasesSummary: Caspase-3 inhibitor,selective non-peptide
- A4400 BMS 299897Summary: γ--secretase inhibitor, potent and orally active
- A4411 CalpeptinSummary: Ca2+-dependent protease,calpain inhibitor
- A4434 CL 82198 hydrochlorideSummary: Selective MMP-13 inhibitor
- A4401 Compound WSummary: γ-secretase inhibitor
- A4435 CP 471474Summary: Broad spectrum MMP inhibitor
- A4425 DPPI 1c hydrochlorideSummary: DPP-IV Inhibitor